Literature DB >> 17106496

Wegener granulomatosis.

Nichole Graves1.   

Abstract

Entities:  

Year:  2006        PMID: 17106496      PMCID: PMC1618758          DOI: 10.1080/08998280.2006.11928198

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


× No keyword cloud information.
  15 in total

Review 1.  Anti-neutrophil cytoplasm-associated glomerulonephritis.

Authors:  Matthew David Morgan; Lorraine Harper; Julie Williams; Caroline Savage
Journal:  J Am Soc Nephrol       Date:  2006-04-19       Impact factor: 10.121

Review 2.  Antineutrophil cytoplasmic antibodies.

Authors:  Xavier Bosch; Antonio Guilabert; Josep Font
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

3.  Wegener's granulomatosis with a possible thyroidal involvement.

Authors:  Hakan Ozdogu; Can Boga; Filiz Bolat; Melek Eda Ertorer
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

4.  Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.

Authors:  Emily C Somers; Wendy Marder; Gregory M Christman; Vladimir Ognenovski; W Joseph McCune
Journal:  Arthritis Rheum       Date:  2005-09

Review 5.  Pharmacological therapy for Wegener's granulomatosis.

Authors:  Eric S White; Joseph P Lynch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Wegener's granulomatosis: the relationship between ocular and systemic disease.

Authors:  S L Harper; E Letko; C M Samson; P Zafirakis; V Sangwan; Q Nguyen; H Uy; S Baltatzis; C S Foster
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

Review 7.  Respiratory system involvement in systemic vasculitides.

Authors:  P Manganelli; P Fietta; M Carotti; A Pesci; F Salaffi
Journal:  Clin Exp Rheumatol       Date:  2006 Mar-Apr       Impact factor: 4.473

8.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

9.  Clinical features and outcome of patients with both ANCA and anti-GBM antibodies.

Authors:  Jeremy B Levy; Tarig Hammad; Anne Coulthart; Tammy Dougan; Charles D Pusey
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

Review 10.  The antineutrophil cytoplasmic antibody-associated vasculitides.

Authors:  Philip Seo; John H Stone
Journal:  Am J Med       Date:  2004-07-01       Impact factor: 4.965

View more
  1 in total

1.  Autoimmune dysfunction and subsequent renal insufficiency in a collegiate female athlete: a case report.

Authors:  James E Leone; Amie Kern; Joshua D Williamson; Robert M Colandreo
Journal:  J Athl Train       Date:  2010 Nov-Dec       Impact factor: 2.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.